Release Date: June 5, 2022
Expiration Date: July 30, 2022
Activity Overview
This educational activity is an archive of the live virtual presentation held on June 4, 2022.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, surgical oncologists, pathologists, nurses, and other oncology healthcare professionals involved in the treatment of cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Outline key features of liquid biopsies and how they differ from conventional biopsies in the diagnosis and monitoring of cancer
- Explain evidence concerning the reliability of existing and emerging liquid biopsy technologies in cancer care
- Evaluate the relevance of multiple forms of liquid biopsy in the biomarker-driven management of multiple common and less common cancer types
- Summarize the latest evidence concerning the use of liquid biopsy and best practices for realworld applications of these tests
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC
Disclosures: Consultant: Amgen, AstraZeneca, Daiichi Sankyo Eli Lilly, Genentech, Janssen, Marati, Merck, Novartis, Pfizer, Takeda.
David R. Gandara, MD
Professor of Medicine Emeritus
Co-Director, Center for Experimental Therapeutics in Cancer
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Adjunct Clinical Professor, Translational and Clinical Research Program, University of Hawaii Cancer Center
Chief Medical Officer, International Society of Liquid Biopsy
Sacramento, CA
Disclosures: Grant/Research Support: Amgen, AstraZeneca, Genentech, Merck; Consultant: Adagene (Institutional), AstraZeneca (Institutional), Biotech (Institutional), Guardant Health (Institutional), IO Oncocyte (Institutional), Lilly, Merck, Novartis, OncoHost (Institutional), Roche-Genentech (Institutional).
Aparna R. Parikh, MD, MS
Assistant Professor of Medicine, Harvard Medical School
Director, of the MGH Cancer Center's Global Cancer Care Program
Massachusetts General Hospital Cancer Center
Tucker Gosnell Center for Gastrointestinal Malignancies
Termeer Center for Targeted Therapies
Boston, MA
Disclosures: Consultant: Biofi delity, Checkmate Pharmaceuticals, Eli Lilly, FMI, Genconn, Guardant and Abbvie, Inivata, Natera, Pfizer, Value Analytics Lab; Shareholder: Equity C2i Genomics, XGenomes; Other: DSMC for a Roche study and has received research funding to the Institution from BMS, Daiichi Sankyo, Genentech, Mirati, Natera, Novartis, PMV Pharmaceuticals, Plexxicon, PureTech, and Takeda.
Heather A. Parsons, MD, MPH
Professor, Medicine, Harvard Medical School
Physician, Susan F. Smith Center for Women's Cancers
Dana-Farber Cancer Institute
Boston, MA
Disclosures: Grant/Research Support: Puma Biotechnology (research support to institute).
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
